Optimizing PBMC Viability and Recovery: Updated Best Practices for 2026

In biomedical research, the viability and recovery of peripheral blood mononuclear cells (PBMCs) determine the reliability of downstream results. Over the past few years, advances in donor screening, cryopreservation, and logistics have dramatically improved the consistency of primary immune cell performance. Yet, small variables—temperature shifts, prolonged DMSO exposure, or donor differences—still account for major discrepancies…

For More Information

CGT Global Launches CellsExpress Bulk Cell Isolation

CGT Global Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, CGT Global is now proud to offer select isolated products…

For More Information

CGT Global Opens Facility In Northern Nevada

RENO, Nev., April 5, 2021 /PRNewswire/ — StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada. The property development will include a state-of-the-art cell collection center as well as a large-scale warehouse that contains a centralized shipping location for the company. The site will also be a new…

For More Information

Choosing a Biospecimen Provider

Imagine the following scenario. You are close to finalizing the development of a new drug or assay before it enters into clinical trials. However, you encounter a slight setback which requires specific cells you are evaluating to be retested in a key experiment….and you don’t have any vials left! These cells are from a unique…

For More Information

Potential of CRISPR-Cas9-based Technology to Treat Congenital Amegakaryocytic Thrombocytopenia (CAMT)

A single mutation in a gene can lead to rare inherited diseases, such as cystic fibrosis, Tay-Sachs, and sickle-cell anemia, and are often difficult to treat and, for most, have no cure. However, with the current advances in CRISPR-Cas9 genome engineering technology, it may be possible to introduce new immunotherapies to treat these and other…

For More Information

CGT Global Cells in the Development of Humanized Mice

The human body is a complex biological system. In order to fully understand this complex system, in vivo (live) analysis is often required. However, the study of human biology in vivo is severely limited due to ethical and technical constraints. In place of human models, humanized mice have been created to fill this role. These…

For More Information